Avient Announces Second Quarter 2025 Results... Avient Announces Quarterly Dividend... Avient To Hold Second Quarter 2025 Conference Call...

Homepage // News Center // Avient Site in Taiwan Earns ISO 13485 Accreditation; Fourth Source for MEVOPUR™ ‘Medical-Grade’ Materials TAOYUAN, Taiwan – January 19, 2022 – Avient Corporation, a premier provider of specialized and sustainable material solutions and services, today announced the ISO 13485:2016 certification of its production site in Taoyuan, Taiwan (near Taipei).  About Avient

However, supply issues caused by available materials not reaching their destination due to geopolitical restrictions are easier to solve. Avient’s Mevopur™ portfolio and risk mitigation concept can help healthcare manufacturers on the journey to increased security of supply for plastics used in their products. Help protect or enhance the performance of polymers used in medical devices, diagnostics and pharmaceutical packaging.

However, supply issues caused by available materials not reaching their destination due to geopolitical restrictions are easier to solve. Avient’s Mevopur™ portfolio and risk mitigation concept can help healthcare manufacturers on the journey to increased security of supply for plastics used in their products. Help protect or enhance the performance of polymers used in medical devices, diagnostics and pharmaceutical packaging.

However, supply issues caused by available materials not reaching their destination due to geopolitical restrictions are easier to solve. Avient’s Mevopur™ portfolio and risk mitigation concept can help healthcare manufacturers on the journey to increased security of supply for plastics used in their products. Help protect or enhance the performance of polymers used in medical devices, diagnostics and pharmaceutical packaging.

However, supply issues caused by available materials not reaching their destination due to geopolitical restrictions are easier to solve. Avient’s Mevopur™ portfolio and risk mitigation concept can help healthcare manufacturers on the journey to increased security of supply for plastics used in their products. Help protect or enhance the performance of polymers used in medical devices, diagnostics and pharmaceutical packaging.

However, supply issues caused by available materials not reaching their destination due to geopolitical restrictions are easier to solve. Avient’s Mevopur™ portfolio and risk mitigation concept can help healthcare manufacturers on the journey to increased security of supply for plastics used in their products. Help protect or enhance the performance of polymers used in medical devices, diagnostics and pharmaceutical packaging.

Avient will feature its portfolio of advanced composite materials a... Dyneema® Launches New Fiber for Protective Gloves, Initiating Paradigm Shift in Light-Weight, Comfort and Strength... Avient to Present a Broad Array of Innovative and Sustainable Materials Solutions at Chinaplas 2025...

Polymers can be processed at a lower cost than metals, reducing overall material expenses. Using engineered polymers in electric vehicle batteries presents numerous advantages over traditional metal-based materials. Discover Avient's Solutions for EV Batteries

Polymers can be processed at a lower cost than metals, reducing overall material expenses. Using engineered polymers in electric vehicle batteries presents numerous advantages over traditional metal-based materials. Discover Avient's Solutions for EV Batteries